Generic Anti-Seizure Drug Approved

WEDNESDAY, Oct. 10 (HealthDay News) -- The U.S. Food and Drug Administration has approved the first generic versions of the anticonvulsant Trileptal (generic name: oxcarbazepine) to treat partial seizures in people 4 years old and older.

Oxcarbazepine tablets in strengths of 150 mg., 300 mg., and 600 mg. will be produced by Roxane Laboratories Inc., Glenmark Pharmaceuticals Ltd., and Sun Pharmaceutical Industries Ltd.

Trileptal, made by Novartis, was the 74th best-selling brand-name medication in the United States, according to the publication Drug Topics, the FDA said in a statement.

Some cases of serious skin reaction have been reported in people who used Trileptal, the agency said. Other side effects may include dizziness and drowsiness.

More information

Visit the FDA to learn more.

Join the Discussion
blog comments powered by Disqus
 
You Might Also Like...
See It, Share It
PHOTO: Juan Pablo Montoya, of Colombia, celebrates after winning the 99th running of the Indianapolis 500 auto race at Indianapolis Motor Speedway in Indianapolis, Sunday, May 24, 2015.
Darron Cummings/AP Photo
PHOTO:
Mark J. Rebilas-USA TODAY Sports/Reuters
PHOTO: Actress/comedian Anne Meara attends the Comedy Hall Of Fame An Evening With Stiller And Meara at Museum of the Moving Image on March 10, 2011 in New York City.
George Napolitano/Getty Images